Furthermore, d16HER2+ mammary tumors exhibited a higher frequency of CD29high/CD24+/SCA1low cells, a peculiar population enriched in murine mammary stem cells [64], than their FL-HER2+ cell counterparts [38]. This evidence concerns the gene ERBB2 and breast cancer.